FDA Import Refusal SCS-9591315-2/13/1 — SHAANXI PULIZHONGHE BIOPHARMACEUTIC
The FDA refused shipment SCS-9591315-2/13/1 from SHAANXI PULIZHONGHE BIOPHARMACEUTIC (China) on Jun 3, 2025. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75
Refusal Details
- Date
- Jun 3, 2025
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 66VAM99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75